We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Katie Okamoto Katie Okamoto is an editor focusing on sustainability. She’s ...

Event summary produced by The Globe and Mail Events team. The Globe’s editorial department was not involved. Generative and agentic AI have the potential to reshape how organizations compete—but only ...

KeyBanc downgraded the PRIM stock to “Sector Weight” from “Overweight” and currently has no price target. Primoris roughly halved its 2026 adjusted earnings per share outlook to $2.05-$2.60.

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

More than a decade ago, the economist Erik Brynjolfsson made a prediction: AI would change everything. Humans began using tools millions of years ago. They cultivated grain and domesticated animals, ...

BOSTON, June 23, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Primoris Services Corporation (NYSE: PRIM) for potential securities law violations. Investors who have lost money in their ...

Objectives This study aims to investigate the knowledge, attitudes and practices (KAP) regarding diabetic nephropathy among patients with diabetes. Design A cross-sectional survey was conducted.